NEULEPTIL 10 MG — DIN 01926756
PERICIAZINE : 10 MG · SEARCHLIGHT PHARMA INC · DROPS · wholesale supply in Canada
Health Canada status: MARKETED
What is NEULEPTIL?
NEULEPTIL 10 MG contains PERICIAZINE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 01926756, held by SEARCHLIGHT PHARMA INC, supplied as DROPS for ORAL administration. Health Canada currently lists it as marketed, status dated 27-Jan-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is NEULEPTIL used for?
Adjunctive medication in some psychotic patients; control of residual prevailing hostility, impulsiveness and aggressiveness.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Is there a generic Periciazine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
Only one market authorization holder has a Canadian DIN containing Periciazine — 4 DINs, of which 3 are currently marketed. There is no second Canadian source today, so a supply interruption on this holder has no domestic substitute at the same molecule.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| SEARCHLIGHT PHARMA INC | 4 | 3 | NEULEPTIL | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 10 MG |
|---|---|
| Dosage form | DROPS |
| Route | ORAL |
| Pack configuration (monograph) | Capsules: Bottles of 100. Oral Drops: 100 mL bottle with calibrated dropper. |
| Storage | Not explicitly stated in provided text (refer to section 11 of full monograph). |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Periciazine |
|---|---|
| ATC code | N05AC01 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01926756 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1926756 |
| Brand name | NEULEPTIL |
| Generic / active ingredient | PERICIAZINE : 10 MG |
| Market authorization holder | SEARCHLIGHT PHARMA INC |
| Health Canada schedule | Prescription |
| ATC code | N05AC01 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N05AC |
| Current status | MARKETED |
| Status date | 27-Jan-2023 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Adults: 5-20 mg AM, 10-40 mg PM. Elderly: Start at 5 mg/day. Children (5+): 2.5-10 mg AM, 5-30 mg PM. Titrate to minimum effective dose. Reserve major portion of dose for evening.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to phenothiazines; circulatory collapse; comatose states; spinal/regional anesthesia; blood dyscrasias; angle-closure glaucoma; urinary retention; renal or liver insufficiency.
Warnings and precautions
Increased mortality in elderly patients with dementia. Risk of QT prolongation, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, and Venous Thromboembolism. May impair driving ability.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
3 of 4 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| NEULEPTIL | 10 MG | CAPSULE | SEARCHLIGHT PHARMA INC | MARKETED | 01926772 |
| NEULEPTIL | 5 MG | CAPSULE | SEARCHLIGHT PHARMA INC | MARKETED | 01926780 |
| NEULEPTIL | 20 MG | CAPSULE | SEARCHLIGHT PHARMA INC | DORMANT | 01926764 |
2 · Same class — other molecules in ATC N05AC
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Periciazine | NEULEPTIL | 4 | 3 | Yes |
| Thioridazine | MELLARIL · MELLARIL TAB 100MG · MELLARIL TAB 10MG · MELLARIL TAB 200MG · +18 more | 23 | 0 | Not in Canada |
| Mesoridazine | SERENTIL TAB 10MG · SERENTIL TAB 25MG · SERENTIL TAB 50MG | 3 | 0 | Not in Canada |
| Pipotiazine | PIPORTIL L4 | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N05A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N05AH | Asenapine · Clozapine · Loxapine · Olanzapine · Quetiapine | 589 | 220 |
| N05AX | Aripiprazole · Brexpiprazole · Cariprazine · Paliperidone · Risperidone | 352 | 175 |
| N05AE | Lurasidone · Ziprasidone | 60 | 41 |
| N05AB | Fluphenazine · Perphenazine · Prochlorperazine · Thioproperazine · Trifluoperazine | 104 | 10 |
| N05AD | Droperidol · Haloperidol | 53 | 9 |
| N05AF | Flupentixol · Tiotixene · Zuclopenthixol | 25 | 8 |
| N05AA | Chlorpromazine · Levomepromazine · Promazine | 51 | 8 |
| N05AN | Lithium | 26 | 7 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is NEULEPTIL called?
The same molecule, Periciazine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Neulactil | Latin | Australia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.